Charles Philips (1787–1859), ‘Speech of Mr. Philips in the Case of Guthrie V. Sterne, Delivered in the Court of Common Pleas, Dublin’, the Speeches of Charles Philips, Esq

Autor: François Soyer, Katie Barclay

Publikováno v: Emotions in Europe 1517–1914

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::488272af4c52e945bd568c5e07f611f3
https://doi.org/10.4324/9781003175537-36

Commentary on Guthrie v. Conroy

Autor: L. Camille Hébert

Publikováno v: Feminist Judgments: Rewritten Tort Opinions

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::712e9b0216b559a83b49879010357ff3
https://doi.org/10.1017/9781108613293.011

A self-efficacy enhancement alcohol reduction intervention for men on-remand in prison: the APPRAISE feasibility pilot RCT.

Autor: Holloway A; Nursing Studies, School of Health in Social Science, University of Edinburgh, Edinburgh, UK., Waller G; Centre for Crime, Harm Prevention and Security, School of Social Sciences, Humanities & Law, Teesside University, Middlesbrough, Tees Valley, UK., Ferguson J; School of Social Sciences, Humanities & Law, Teesside University, Middlesbrough, Tees Valley, UK., Guthrie V; Nursing Studies, School of Health in Social Science, University of Edinburgh, Edinburgh, UK., Smith JB; Institute of Clinical Nursing Science, Charité Center 1 for Health and Human Sciences, Charité-Universitätsmedizin, Berlin, Germany., Boyd J; Humankind, Inspiration House, Unit 22 Bowburn North Industrial Estate, Bowburn, UK., Mercado S; Nursing Studies, School of Health in Social Science, University of Edinburgh, Edinburgh, UK., Rees J; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, the University of Edinburgh, Edinburgh BioQuarter, UK., Anthony Parker R; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, the University of Edinburgh, Edinburgh BioQuarter, UK., Stoddart A; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, the University of Edinburgh, Edinburgh BioQuarter, UK., Bray JW; Bryan School of Business and Economics, University of North Carolina at Greensboro, Greensboro, NC, USA., Coulton S; Centre for Health Service Studies, George Allen Wing, Cornwallis Building, University of Kent, Canterbury, UK., Hunt K; Institute for Social Marketing, University of Stirling, Stirling, UK., Stadler G; Gender in Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Sondhi A; Therapeutic Solutions (Addictions), London, UK., Smith P; Nursing Studies, School of Health in Social Science, University of Edinburgh, Edinburgh, UK., Stenhouse R; Nursing Studies, School of Health in Social Science, University of Edinburgh, Edinburgh, UK., Conaglen P; Department of Public Health and Health Policy, NHS Lothian, Edinburgh, UK., Sheikh A; Usher Institute of Population Health Sciences and Informatics, the University of Edinburgh, Edinburgh, UK., Newbury-Birch D; Centre for Crime, Harm Prevention and Security, School of Social Sciences, Humanities & Law, Teesside University, Middlesbrough, Tees Valley, UK.

Publikováno v: Public health research (Southampton, England) [Public Health Res (Southampt)] 2024 Nov; Vol. 12 (11), pp. 1-186.

Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer.

Autor: Bossé Y; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Medicine, Université Laval, Quebec City, Canada. Electronic address: yohan.bosse@criucpq.ulaval.ca., Dasgupta A; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Abadier M; Translational Medicine Early Oncology, AstraZeneca, Waltham, MA, USA., Guthrie V; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Song F; Translational Medicine Early Oncology, AstraZeneca, Munich, Germany., Saavedra Armero V; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Gaudreault N; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Orain M; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Lamaze FC; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Melton C; GRAIL, LLC, Menlo Park, CA, USA., Nance T; GRAIL, LLC, Menlo Park, CA, USA., Hung T; GRAIL, LLC, Menlo Park, CA, USA., Hodgson D; Translational Medicine Early Oncology, AstraZeneca, Cambridge, United Kingdom., Abbosh C; Translational Medicine Early Oncology, AstraZeneca, Cambridge, United Kingdom., Joubert P; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Biology, Pathology and Medical Biochemistry, Université Laval, Quebec City, Canada.

Publikováno v: Cancer letters [Cancer Lett] 2024 Jul 10; Vol. 594, pp. 216984. Date of Electronic Publication: 2024 May 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.